Tan JA, et al. Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis 2017; 76:1566–1574.

• PubMed
Tan JA, Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis 2017; 76:1566–1574.)| false
• Search Google Scholar
• Export Citation

Robson J, et al. Damage in the ANCA-associated vasculitides: Long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis 2015; 74:177–184.

• PubMed
Robson J, Damage in the ANCA-associated vasculitides: Long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis 2015; 74:177–184.)| false
• Search Google Scholar
• Export Citation

Robson JC, et al. Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Int 2018; 38:675–682.

• PubMed
Robson JC, Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Int 2018; 38:675–682.)| false
• Search Google Scholar
• Export Citation

Jayne DRW, et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 2017; 28:2756–2767.

• PubMed
Jayne DRW, Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 2017; 28:2756–2767.)| false
• Search Google Scholar
• Export Citation

Pepper RJ, et al. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis [published online ahead of print Sep 18, 2018]. Rheumatology (Oxford) doi: 10.1093/rheumatology/key288.

• PubMed
Pepper RJ, A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis [published online ahead of print Sep 18, 2018]. Rheumatology (Oxford) doi: 10.1093/rheumatology/key288.)| false
• Search Google Scholar
• Export Citation

McAdoo SP, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant 2018; 33:899.

• PubMed
McAdoo SP, Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant 2018; 33:899.)| false
• Search Google Scholar
• Export Citation

Cortazar FB, et al. Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep 2018; 3:394–402.

• PubMed
Cortazar FB, Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep 2018; 3:394–402.)| false
• Search Google Scholar
• Export Citation

Furuta S, et al. Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): Protocol for a multicentre, open-label, randomised controlled trial. BMJ Open 2017; 7:e018748.

• PubMed
Furuta S, Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): Protocol for a multicentre, open-label, randomised controlled trial. BMJ Open 2017; 7:e018748.)| false
• Search Google Scholar
• Export Citation

Touma Z, Gladman DD. Current and future therapies for SLE: Obstacles and recommendations for the development of novel treatments. Lupus Sci Med 2017; 4:e000239.

• PubMed
Touma Z, Gladman DD. Current and future therapies for SLE: Obstacles and recommendations for the development of novel treatments. Lupus Sci Med 2017; 4:e000239.)| false
• Search Google Scholar
• Export Citation

Houssiau FA, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010; 69:61–64.

• PubMed
Houssiau FA, The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010; 69:61–64.)| false
• Search Google Scholar
• Export Citation

Ruiz-Irastorza G, et al. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the lupus-Cruces and lupus-Bordeaux cohorts. Autoimmun Rev 2017; 16:826–832.

• PubMed
Ruiz-Irastorza G, Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the lupus-Cruces and lupus-Bordeaux cohorts. Autoimmun Rev 2017; 16:826–832.)| false
• Search Google Scholar
• Export Citation

Condon MB, et al. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 2013; 72:1280–1286.

• PubMed
Condon MB, Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 2013; 72:1280–1286.)| false
• Search Google Scholar
• Export Citation

Rovin BH, et al. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis [published online ahead of print Nov 5, 2018]. Kidney Int doi: 10.1016/j.kint.2018.08.025.

• PubMed
Rovin BH, A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis [published online ahead of print Nov 5, 2018]. Kidney Int doi: 10.1016/j.kint.2018.08.025.)| false
• Search Google Scholar
• Export Citation

Holden NJ, et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: A clinically relevant cellular process. Ann Rheum Dis 2011; 70:2229–2233.

• PubMed
Holden NJ, ANCA-stimulated neutrophils release BLyS and promote B cell survival: A clinically relevant cellular process. Ann Rheum Dis 2011; 70:2229–2233.)| false
• Search Google Scholar
• Export Citation